- Poster presentation
- Open Access
Understanding heterogeneity in the host response to Staphylococcus aureus infection for prognostic biomarker discovery
© Dinoso et al.; licensee BioMed Central Ltd. 2014
Published: 3 December 2014
Invasive Staphylococcus aureus infections remain an unmet medical need with the issues of drug resistance (MRSA) and mortality. Understanding clinical trial data in the development of antibiotics to S. aureus is complicated by heterogeneous clinical outcomes (that is, length of hospitalization, mortality, treatment response), which makes interpretation of drug efficacy challenging. Identification of prognostic biomarkers of different biological processes that associate with clinical outcomes would aid in clinical development of novel therapies for S. aureus infections.
In an effort to discover biomarkers that differentiate patient populations based on clinical outcomes following S. aureus infection, we retrospectively analyzed published gene expression datasets of S. aureus infection and sepsis.
We identified a leukocyte gene expression signature that positively correlated with S. aureus disease severity . This severity signature was enriched for genes associated with neutrophils but was not solely explained by increased percentage of neutrophils. This set of genes was also associated with severity in sepsis, with higher expression in patients with septic shock compared with sepsis  and in nonsurvivors compared with survivors of septic shock . Our in vitro studies revealed that the severity signature may reflect an increase in circulating immature neutrophils or band cells which has been previously reported in the context of bacterial stimuli and sepsis [4, 5]. This line of evidence is consistent with a recent report by Guerin and colleagues that demonstrated that quantification of immature neutrophils by flow cytometry was prognostic for sepsis mortality .
To extend the insight gained from our retrospective analysis and in vitro studies, we are conducting a longitudinal, non-interventional clinical study of patients with S. aureus bacteremia. The goal of the study is to associate molecular metrics (gene expression, plasma protein levels, immune cell subsets) with clinical outcomes (length of hospitalization, mortality, treatment response, readmission for recalcitrant infection). Our preliminary data show an association between grade of sepsis or infection localization and increased immature neutrophils as well as monocyte subsets that can promote inflammation or immune exhaustion. Ongoing experiments are designed to understand the impact of these cellular phenotypes on disease progression and to identify robust protein or RNA biomarkers that are prognostic for clinical outcomes.
- Banchereau R, Jordan-Villegas A: Host immune transcriptional profiles reflect the variability in clinical disease manifestations in patients with Staphylococcus aureus infections. PLoS ONE 2012, 7: e34390. 10.1371/journal.pone.0034390View ArticlePubMedPubMed CentralGoogle Scholar
- Wong HR, Cvijanovich N: Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009, 37: 1558-1566. 10.1097/CCM.0b013e31819fcc08View ArticlePubMedPubMed CentralGoogle Scholar
- Wynn JL, Cvijanovich NZ: The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med 2011, 17: 1146-1156.View ArticlePubMedPubMed CentralGoogle Scholar
- Taneja R, Sharma AP: Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling. Shock 2008, 30: 618-622. 10.1097/SHK.0b013e318173ef9cView ArticlePubMedGoogle Scholar
- Pillay J, Ramakers P: Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol 2010, 88: 211-220. 10.1189/jlb.1209793View ArticlePubMedGoogle Scholar
- Guerin E, Orabona M: Circulating immature granulocytes with T-cell killing functions predict sepsis deterioration. Crit Care Med 2014, 42: 2007-2018. 10.1097/CCM.0000000000000344View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.